RAPP — Rapport Therapeutics, Inc. catalysts
Next verified catalyst
2026-09-01 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I D · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With B
Phase 2 · Bipolar 1 Disorder |
RAPP Rapport Therapeutics, Inc. | RAP-219 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|